The information below reflects brand-reported review data from Bodybuilding Health+ published materials and should not be interpreted as typical results, guaranteed outcomes, or medical claims
10.1016/s0891-5849(00)00244-6 [DOI] [PubMed] [Google Scholar] 32.Grimm T, Skrabala R, Chovanov Z, Muchov J, Sumegov K, Liptkov A, et al
Prior research has shown that estrogen amplifies GH release by counteracting somatostatin inhibition and enhancing GHRH signaling, while antiestrogens may reduce IGF-1 receptor expression, thereby modifying the biological effects of IGF-1 [2]
Nicolucci A, Ceriello A, Di Bartolo P, Corcos A, Orsini Federici M (2020) Rapid-acting insulin analogues versus regular human insulin: a meta-analysis of effects on glycemic control in patients with diabetes
The GLP-1 RA monitoring report describes more detailed information about the overall population of patients being prescribed these medications (including demographics and comorbidities), and the proportion and characteristics of patients who filled a GLP-1 RA prescription over time using dispenses
Unlike traditional Rx brands that rely on physician advocacy alone, GLP-1s need direct consumer brand equity as well as providing experts with clear reasons to recommend if they are to be victorious in the pharma-to-wellness crossover and secure distribution channels
